<DOC>
	<DOC>NCT00867165</DOC>
	<brief_summary>The purpose of this study is to determine the effect of ezetimibe 10 mg/day compared to placebo on the reduction of low-density lipoprotein cholesterol (LDL-C) from baseline to 12 weeks of treatment in children &gt;=6 to &lt;=10 years old with primary hypercholesterolemia. The study will also evaluate the effect of ezetimibe on total cholesterol (TC), apolipoprotein B (Apo B), high-density lipoprotein cholesterol (HDL-C), non-HDL-C, and triglycerides (TG). The safety of ezetimibe in this subject population will also be evaluated.</brief_summary>
	<brief_title>Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Each subject may be of either sex and of any race/ethnicity, and must be &gt;=6 and &lt;=10 years of age, with a diagnosis of primary hypercholesterolemia (heterozygous familial or nonfamilial) despite being on a lipidlowering diet for at least 3 months with a LDLC of &gt;159mg/dL Each subject's parent/guardian must be willing to give written informed consent on his/her behalf. Each subject must not: Have known hypersensitivity or any contraindication to ezetimibe. Have use of any investigational drugs within 30 days of study entry. Be a member or a family member of the personnel of the investigational or sponsor staff directly involved with this trial. Be a female of childbearing potential who is pregnant, intends to become pregnant, or is nursing Have known congenital cardiac disorder. Have documented or laboratory values consistent with homozygous familial hypercholesterolemia (HoFH). Be known to be human immunodeficiency virus (HIV) positive.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>heterozygous familial hypercholesterolemia</keyword>
	<keyword>nonfamilial hypercholesterolemia</keyword>
</DOC>